Terms: = Brain cancer AND USP8, FLJ34456, 9101, ENSG00000138592, KIAA0055, P40818, MGC129718, UBPY, HumORF8 AND Diagnosis
5 results:
1. Molecular genetic testing in the management of pituitary disease.
Coopmans EC; Korbonits M
Clin Endocrinol (Oxf); 2022 Oct; 97(4):424-435. PubMed ID: 35349723
[TBL] [Abstract] [Full Text] [Related]
2. The clinical aspects of pituitary tumour genetics.
Dénes J; Korbonits M
Endocrine; 2021 Mar; 71(3):663-674. PubMed ID: 33543431
[TBL] [Abstract] [Full Text] [Related]
3. Somatic and germline mutations in the pathogenesis of pituitary adenomas.
Vandeva S; Daly AF; Petrossians P; Zacharieva S; Beckers A
Eur J Endocrinol; 2019 Dec; 181(6):R235-R254. PubMed ID: 31658440
[TBL] [Abstract] [Full Text] [Related]
4. [Pituitary adenomas].
Honegger J; Nasi-Kordhishti I; Giese S
Nervenarzt; 2019 Jun; 90(6):568-577. PubMed ID: 30997549
[TBL] [Abstract] [Full Text] [Related]
5. Hypercortisolism due to a Pituitary Adenoma Associated with Beckwith-Wiedemann Syndrome.
Brioude F; Nicolas C; Marey I; Gaillard S; Bernier M; Das Neves C; Le Bouc Y; Touraine P; Netchine I
Horm Res Paediatr; 2016; 86(3):206-211. PubMed ID: 27255538
[TBL] [Abstract] [Full Text] [Related]
